McGraw-Hill Professional partners with JAMA to launch JAMAevidence

McGraw-Hill Professional has partnered with the Journal of the American Medical Association (JAMA) to develop and launch JAMAevidence, a learning tool and digital resource for medical students, residents, educators and clinicians. The online resource (jamaevidence.com) provides full-text access to The User's Guides to the Medical Literature, as well as The Rational Clinical Examination. 
You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.